NimbleGen Hopes to Transform Custom Microarray Market | GenomeWeb

NEW YORK, February 27 – Mike Treble, CEO of NimbleGen, believes that he can do for the microarray market what the PC did for computing, namely develop a technology cheap enough and easy enough to use to allow individuals to make their own high-quality microarrays.

"Our long term strategy over the next two to three years is to produce instruments that will allow core centers to produce their own DNA chips,” Treble told GenomeWeb. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.